Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women (Q24236763)

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Antiretroviral-associated toxicity among HIV-1-seropositive pregnant women in Mozambique receiving nevirapine-based regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

HIV-1 persists in breast milk cells despite antiretroviral treatment to prevent mother-to-child transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Safety of nevirapine-containing antiretroviral triple therapy regimens to prevent vertical transmission in an African cohort of HIV-1-infected pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Nevirapine-associated toxicity in HIV-infected Thai men and women, including pregnant women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Lactic acidemia in human immunodeficiency virus-uninfected infants exposed to perinatal antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Prevalence of resistance to nevirapine in mothers and children after single-dose exposure to prevent vertical transmission of HIV-1: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Prophylactic antiretroviral regimens for prevention of mother-to-child transmission of HIV in resource-limited settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Adherence to antiretrovirals among US women during and after pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Antiretroviral resistance in viral isolates from HIV-1-transmitting mothers and their infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Safety and efficacy of initiating highly active antiretroviral therapy in an integrated antenatal and HIV clinic in Johannesburg, South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

No relation between in-utero exposure to HAART and intrauterine growth retardation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Combination antiretroviral therapy in 100 HIV-1-infected pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Antiretroviral drugs for preventing mother-to-child transmission of HIV in sub-Saharan Africa: balancing efficacy and infant toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Is antiretroviral therapy during pregnancy associated with an increased risk of preterm delivery, low birth weight, or stillbirth?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Lack of an effect of protease inhibitor use on glucose tolerance during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Effects of antiretroviral agents during pregnancy on liver enzymes and amylase in HIV-exposed, uninfected newborn infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Combination antiretroviral therapy and duration of pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Exposure to antiretroviral therapy in utero or early life: the health of uninfected children born to HIV-infected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Antiretroviral therapy-associated modulation of Th1 and Th2 immune responses in HIV-infected pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Selection of resistance mutations in pregnant women receiving zidovudine and lamivudine to prevent HIV perinatal transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Increased rate of prematurity associated with antenatal antiretroviral therapy in a German/Austrian cohort of HIV-1-infected women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Maternal toxicity with continuous nevirapine in pregnancy: results from PACTG 1022.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Protease inhibitor-based antiretroviral therapy and glucose tolerance in pregnancy: AIDS Clinical Trials Group A5084.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Operational effectiveness and 36 week HIV-free survival in the South African programme to prevent mother-to-child transmission of HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Protease inhibitor use and the incidence of diabetes mellitus in a large cohort of HIV-infected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Lipids and lactate in human immunodeficiency virus-1 infected pregnancies with or without protease inhibitor-based therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Pregnant women with HIV infection can expect healthy survival: three-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

What can we do to reduce mother to child transmission of HIV?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Strategies to prevent mother-to-child transmission of HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Adherence to antiretroviral treatment among pregnant and postpartum HIV-infected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Safety of antiretroviral prophylaxis of perinatal transmission for HIV-infected pregnant women and their infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Maternal antiretrovirals and hepatic enzyme, hematologic abnormalities among human immunodeficiency virus type 1-uninfected infants: the NISDI perinatal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Adverse effects of tenofovir use in HIV-infected pregnant women and their infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Effect of postpartum HIV treatment discontinuation on long-term maternal outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Breastfeeding with maternal antiretroviral therapy or formula feeding to prevent HIV postnatal mother-to-child transmission in Rwanda

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: Pediatric Spectrum of HIV Disease, 1989-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Antiretroviral medications during pregnancy for therapy or prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Maternal antiretroviral drugs during pregnancy and infant low birth weight and preterm birth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Increased risk of adverse pregnancy outcomes in HIV-infected women treated with highly active antiretroviral therapy in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Nelfinavir and nevirapine side effects during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Antiretroviral Therapy and Congenital Abnormalities in Infants Born to HIV-1-Infected Women in the United Kingdom and Ireland, 1990 to 2003

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Antiretroviral therapy and premature delivery in diagnosed HIV-infected women in the United Kingdom and Ireland

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Antiretroviral therapy and congenital abnormalities in infants born to HIV-infected women in the UK and Ireland, 1990-2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Antiretroviral therapy during pregnancy and the risk of an adverse outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Improved obstetric outcomes and few maternal toxicities are associated with antiretroviral therapy, including highly active antiretroviral therapy during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Serious toxicity associated with continuous nevirapine-based HAART in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Safety and efficacy of saquinavir soft-gelatin capsules + zidovudine + optional lamivudine in pregnancy and prevention of vertical HIV transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Maternal toxicity and pregnancy complications in human immunodeficiency virus-infected women receiving antiretroviral therapy: PACTG 316.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Assessing the risk of birth defects associated with antiretroviral exposure during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Resistance to antiretrovirals in HIV-infected pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Clinical response and tolerability to and safety of saquinavir with low-dose ritonavir in human immunodeficiency virus type 1-infected mothers and their infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Maternal viral load and vertical transmission of HIV-1: an important factor but not the only one

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Factors Influencing Gestational Age-Adjusted Birthweight in a National Series of 600 Newborns from Mothers with HIV

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1--a meta-analysis of 15 prospective cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Duration of ruptured membranes and vertical transmission of HIV-1: a meta-analysis from 15 prospective cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads <1000 copies/ml.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Maternal-fetal microtransfusions and HIV-1 mother-to-child transmission in Malawi

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Excess intrauterine fetal demise associated with maternal human immunodeficiency virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Efficacy of short-course AZT plus 3TC to reduce nevirapine resistance in the prevention of mother-to-child HIV transmission: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Mother-child HIV-1 transmission: Timing and determinants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Presence of cell-free human immunodeficiency virus in cervicovaginal secretions is independent of viral load in the blood of human immunodeficiency virus-infected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Breast-milk infectivity in human immunodeficiency virus type 1-infected mothers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Short postexposure prophylaxis in newborn babies to reduce mother-to-child transmission of HIV-1: NVAZ randomised clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Late postnatal transmission of HIV-1 and associated factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000???2006

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

The Cochrane Library and mother-to-child transmission of HIV: an umbrella review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Efficacy of Low-Dose Boosted Saquinavir Once Daily Plus Nucleoside Reverse Transcriptase Inhibitors in Pregnant HIV-1-Infected Women With a Therapeutic Drug Monitoring Strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Obstetric and perinatal complications in HIV-infected women. Analysis of a cohort of 167 pregnancies between 1997 and 2003

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Effect of Perinatal Antiretroviral Drug Exposure on Hematologic Values in HIV‐Uninfected Children: An Analysis of the Women and Infants Transmission Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

Vertical transmission of HIV in Belgium: a 1986-2002 retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

7 January 2021

Antiretroviral agents during pregnancy: consequences on hematologic parameters in HIV-exposed, uninfected newborn infant

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

7 January 2021

Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

7 January 2021

Proposed definitions for in utero versus intrapartum transmission of HIV-1

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

7 January 2021

Influence of highly active antiretroviral treatment (HAART) on risk factors for vertical HIV transmission.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

7 January 2021

Haematological parameters of HIV-1-uninfected infants born to HIV-1-infected mothers

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

7 January 2021

Increased rates of preterm delivery are associated with the initiation of highly active antiretrovial therapy during pregnancy: a single-center cohort study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

7 January 2021

Antiretroviral therapies in pregnancy: maternal, fetal and neonatal effects. Swiss HIV Cohort Study, the Swiss Collaborative HIV and Pregnancy Study, and the Swiss Neonatal HIV Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

7 January 2021

Sexual behavior and injection drug use during pregnancy and vertical transmission of HIV-1

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

7 January 2021

Effect of protease inhibitor therapy on glucose intolerance in pregnancy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

7 January 2021

Expanded services for the prevention of mother-to-child HIV transmission: field acceptability of a pilot program in Lusaka, Zambia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

7 January 2021

Short-term antiretroviral therapy to prevent mother-to-child transmission is safe and results in a sustained increase in CD4 T-cell counts in HIV-1-infected mothers

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008440

7 January 2021

10.1002/14651858.CD008440

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

20238370

1 reference

Consolidated OpenCitations Corpus – April 2017